Study of the Association Between Digital Eye Syndrome With Binocular Vision and the Ocular Surface in Higher Education Students in the Area of Health Technologies

NCT05675475 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2023-01-09

No results posted yet for this study

Summary

The goal of this observational study is to determinate the association between DES and changes in binocular vision and ocular surface. in higher education students in the area of health technologies. The main questions it aims to determine the prevalence of Digital Eye Syndrome (DES); the association between DES and changes in binocular vision and ocular surface; whether the time of use and the type of electronic devices influences the degree and type of symptoms of DES; and to determine whether there is an association between the type of ametropia and the symptoms of DES. Participants will have to answer 3 questionnaires (the Computer Vision Syndrome Questionnaire; the Convergence Insufficiency Symptoms Survey, and the Dry Eye Questionnaire (DEQ-5)) and then they will perform an orthoptic assessment and an assessment of the ocular surface with the tear film Break Up Time (BUT) test.

Conditions

  • Digital Eye Strain

Interventions

OTHER

Exposure

Higher education students from health technologies field exposed to digital devices.

DIAGNOSTIC_TEST

Orthoptic assessment (Outcome measure)

The orthoptic assessment is a non-invasive assessment that will last for 30 min to determine visual parameters related to binocular vision. It will be carried out by the research team in the orthoptics and vision sciences laboratories of the Lisbon School of Health Tecnology.

DIAGNOSTIC_TEST

Tear film Break Up Time (BUT) test (Outcome measure)

The BUT test is a tear film rupture assessment test that allows the stability of the tear film to be evaluated. To perform these tests, it is necessary to instill fluorescein and then it is observed in the slit lamp under illumination with a cobalt blue filter, to count the break-up time.

Sponsors & Collaborators

  • Universidade Nova de Lisboa

    lead OTHER
  • NOVA Medical School | Faculdade de Ciências Médicas, Universidade Nova de Lisboa

    collaborator UNKNOWN
  • Escola Superior de Tecnologia da Saúde de Lisboa (ESTeSL)

    collaborator UNKNOWN
  • University of Évora

    collaborator OTHER
  • CINTESIS@RISE, NOVA Medical School | Faculdade de Ciências Médicas, Universidade Nova de Lisboa

    collaborator UNKNOWN
  • Comprehensive Health Research Center (CHRC), Universidade Nova de Lisboa

    collaborator UNKNOWN

Principal Investigators

  • André Rosário, PhD · NOVA Medical School | Faculdade de Ciências Médicas, Universidade Nova de Lisboa

  • Carla Lança, PhD · Escola Superior de Tecnologia da Saúde de Lisboa (ESTeSL)

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-31
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05675475 on ClinicalTrials.gov